Down Regulation of Microrna-21 is Significantly Associated with Signaling and Activation of the Toll-Like Receptor in Human Lung Transplant Recipients with Primary Graft Dysfunction

Z. Xu,A. Gelman,R. Hachem,T. Mohanakumar
DOI: https://doi.org/10.1016/j.healun.2016.01.243
2016-01-01
Abstract:MicroRNAs (miRNAs) have been identified as regulators of immune responses following human lung transplantation (LTx). This study was undertaken to define the role of miRNAs in primary graft dysfunction (PGD) after human LTx, and characterize the role of miR-21 as a negative regulator of the toll-like receptor (TLR) pathway. MiRNA assays were performed on the cells isolated from bronchoalveolar lavage (BAL) of donor lungs from human LTx recipients with primary graft dysfunction (PGD) (16) and non-PGD (16). Transfection of human monocytic cell line (THP-1) was conducted to determine the function of miR-21. Bioinformatics prediction and validation by reporter genes and western blot assays were performed to identify miR-21 targets. MiRNA profiling of donor BAL samples in PGD patients revealed differentially expressed miRNAs compared to non-PGD, 44 miRNA were up-regulated 80 were down-regulated. Validation using a separate cohort demonstrated significant under expression of miR-21 in PGD BAL collected at 24 hour after LTx. Further, under expression of miR-21 was negatively correlated with PGD grades (PGD2 vs PGD0: p=0.042; PGD3 vs PGD0: p=0.004). Molecular analysis demonstrated that miR-21 targeted key components in TLR signaling including TLR4, IRAK3, and CXCL10. Significantly higher expression levels of TLR4 (p<0.01), IRAK1 (p<0.01), IRAK3 (p<0.01), CXCL10 (p<0.01), MyD88 (p<0.01), PPARA (p<0.01), and PDCD4 (p<0.01) were noted in PGD compared to non-PGD. Finally, incubation of THP-1 cells with cell-free PGD BAL resulted in transactivation of downstream inflammatory cytokines IL1β and TNFα, while increased expression of miR-21 by transfection of miR-21 mimic resulted in marked suppression of IL1β and TNFα. We demonstrate that cells obtained from BAL from LTx recipients with PGD show significant down regulation of miR21 contributing to activation of key components of TLR pathways including TLR4, IRAK3 and CXCL10. We propose that overexpression of miR-21 may protect ischemia-reperfusion induced donor lung injury by inhibiting TLR activation, which could be a potential novel strategy for therapeutic intervention of PGD following human LTx.
What problem does this paper attempt to address?